United States · FDA National Drug Code directory
LYNKUET
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50419-475_35894d94-556e-4bb6-ada9-9d63788de46a
- Product NDC
- 50419-475
- Form
- CAPSULE
- Composition / generic term
- elinzanetant
- Labeler
- Bayer HealthCare Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251024
- Source listing expiry
- 20271231
Source-listed ingredients
- ELINZANETANT — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 5 BLISTER PACK in 1 CARTON (50419-475-05) / 12 CAPSULE in 1 BLISTER PACK (50419-475-01) · 50419-475-05
- 2 BLISTER PACK in 1 CARTON (50419-475-72) / 12 CAPSULE in 1 BLISTER PACK (50419-475-71) · 50419-475-72
- 1 BLISTER PACK in 1 CARTON (50419-475-73) / 12 CAPSULE in 1 BLISTER PACK (50419-475-71) · 50419-475-73
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →